Published in Heart Disease Weekly, May 5th, 2002
Coronary artery disease patients who tested positive for C. pneumoniae showed improved blood flow in the brachial artery and reduced blood levels of two known markers for endothelial dysfunction after five weeks of daily treatment with azithromycin. Patients given placebo did not improve.
Damage to the endothelium, the delicate lining inside arteries and other blood vessels, may lead to atherosclerotic plaques forming and eventually to angina and heart attacks. For...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2002-05-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.